Novo Nordisk invests €726m on API manufacturing
The capital will be used to extend existing facilities, as well as building out an entirely new plant.
Headlines
Global Industry News
-
Yposkesi is on a roll: CDMO’s expanded facility to be operational in early 2024
from BioPharma-Reporter.com
-
Innovate UK announces £30m fund for cancer therapeutics
from BioPharma-Reporter.com
-
Universal mRNA flu vaccine could help protect against future pandemics
from BioPharma-Reporter.com
-
UK lines up training course for hospital and healthcare staff on ATMPs
from BioPharma-Reporter.com
Hot Topics
-
‘Data is the key’: Strategic partnership leverages AI for cancer clinical trial placement
Clinical evolution
-
OneStudyTeam, Antidote partner to support clinical trial recruitment and enrollment
Patient centricity
-
Survey reveals decentralized clinical trial elements that drive participation in studies
Patient centricity
-
Castor bolsters trial solutions platforms to reach more patients and gain RWE
Clinical evolution
